<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00806871</url>
  </required_header>
  <id_info>
    <org_study_id>prövningsprotokoll 080723</org_study_id>
    <nct_id>NCT00806871</nct_id>
  </id_info>
  <brief_title>Steroid Injection Treatment of Carpal Tunnel Syndrome</brief_title>
  <official_title>Local Steroid Injection in the Treatment of Idiopathic Carpal Tunnel Syndrome: A Randomized Double-blind Placebo-controlled Trial Among Patients Planned for Surgical Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the efficacy of injecting steroid into the carpal tunnel
      in relieving symptoms of carpal tunnel syndrome for at least 1 year with outcomes measured
      with patient evaluated symptoms score.Out of the patients referred by primary care, those
      with a clinical diagnosis of CTS who have tried wrist splint and whose symptom severity is
      judged by the examining surgeon to warrant surgery are offered to be put on the waiting list
      for carpal tunnel release. This means a waiting time of approximately 3 months. Patients who
      give informed consent will be asked to attend the outpatient clinic for a physical
      examination followed by allocation to one of the three trial groups. Immediately following
      the allocation the patients will receive the assigned treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      www.biomedcentral.com/1471-2474/11/76
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The CTS symptom severity score after treatment.</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of surgery</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The CTS symptom severity score after treatment</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to surgery</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QuickDASH score</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-6D score</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with the results of treatment (VAS scale)</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Registration of adverse events</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone 40 mg</intervention_name>
    <description>Depo-medrol 40 mg , suspension, injection in the carpal tunnel, one time use
1 ml 40 mg Methylprednisolone + 1 ml 10mg Lidocaine + 1 ml saline</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Depo-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone 80 mg</intervention_name>
    <description>Depo-medrol 80 mg , suspension, injection in the carpal tunnel, one time use.
2 ml 80mg Methylprednisolone + 1 ml 10mg Lidocaine</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Depo-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium chloride</intervention_name>
    <description>Saline solution 0,9%, injection in the carpal tunnel, one time use
1 ml 10 mg Lidocaine + 2 ml saline</description>
    <arm_group_label>C</arm_group_label>
    <other_name>Saline</other_name>
    <other_name>NaCl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary, idiopathic CTS

          -  Age 18-70 years, either gender

          -  Symptom duration of at least 3 months and inadequate response to wrist splint

          -  Symptoms of classic or probable CTS according to the diagnostic criteria in Katz hand
             diagram

          -  Nerve conduction studies showing median neuropathy at the wrist and no other
             abnormalities or, in the absence of abnormal nerve conduction study results, 2
             surgeons should independently diagnose the patient with CTS.

          -  Scheduled for carpal tunnel release (ie, symptom severity indicating need for
             surgery)exclusion criteria

        Exclusion Criteria:

          -  Previous steroid injection for CTS in the same wrist

          -  Inflammatory joint disease, diabetes mellitus· Vibration-induced neuropathy,
             polyneuropathy

          -  Pregnancy

          -  Trauma to the affected hand in the previous year

          -  Previous CTS surgery in the affected hand

          -  Inability to complete questionnaires due to language problem or cognitive disorder

          -  Severe medical illness

          -  Known abuse of drugs and/or alcohol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isam Atroshi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Lund university, department of clinical sciences, Hässleholm hospital, department of orthopedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ortopediska kliniken, sjukvårdsorganisationen Hässleholm/CSK</name>
      <address>
        <city>Hässleholm</city>
        <zip>281 25</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999 Jul 14;282(2):153-8.</citation>
    <PMID>10411196</PMID>
  </reference>
  <reference>
    <citation>Atroshi I, Gummesson C, Johnsson R, McCabe SJ, Ornstein E. Severe carpal tunnel syndrome potentially needing surgical treatment in a general population. J Hand Surg Am. 2003 Jul;28(4):639-44.</citation>
    <PMID>12877853</PMID>
  </reference>
  <reference>
    <citation>Wintman BI, Winters SC, Gelberman RH, Katz JN. Carpal tunnel release. Correlations with preoperative symptomatology. Clin Orthop Relat Res. 1996 May;(326):135-45.</citation>
    <PMID>8620634</PMID>
  </reference>
  <reference>
    <citation>Ahlberg J, Johansson H, Widenfalk B. [Disabling injuries following carpal tunnel syndrome surgery]. Lakartidningen. 2007 Oct 3-9;104(40):2884-6. Swedish.</citation>
    <PMID>17966804</PMID>
  </reference>
  <reference>
    <citation>Benson LS, Bare AA, Nagle DJ, Harder VS, Williams CS, Visotsky JL. Complications of endoscopic and open carpal tunnel release. Arthroscopy. 2006 Sep;22(9):919-24, 924.e1-2. Review.</citation>
    <PMID>16952718</PMID>
  </reference>
  <reference>
    <citation>Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD001554. Review.</citation>
    <PMID>17443508</PMID>
  </reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2008</study_first_submitted>
  <study_first_submitted_qc>December 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2008</study_first_posted>
  <last_update_submitted>April 3, 2012</last_update_submitted>
  <last_update_submitted_qc>April 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

